Evelo Biosciences, Inc. — Form D

Evelo Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-18. The offering totals $30.5M, of which $30.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Mark A PruzanskiDirectorCambridge, MA
Derek P AdamsExecutive OfficerCambridge, MA
Jackie P PapkoffExecutive OfficerCambridge, MA
Noubar B Afeyan, Ph.D.DirectorCambridge, MA
William P DeVaulExecutive OfficerWaltham, MA
David R EpsteinDirectorCambridge, MA
DAVID A BERRY, M.D., PH.D.DirectorCAMBRIDGE, MA
Jennifer P GlennonExecutive OfficerCambridge, MA
Balkrishan (Simba) B Gill, Ph.D.DirectorCambridge, MA
Balkrishan (Simba) B Gill, Ph.D.Executive OfficerCambridge, MA
Lord Ara P DarziDirectorCambridge, MA
Duncan P McHaleExecutive OfficerCambridge, MA
David P PerryDirectorCambridge, MA
Mark P Bodmer, Ph.D.Executive OfficerCambridge, MA
Theodose B Melas-KyriaziDirectorCambridge, MA
Theodose A Melas-KyriaziDirectorCambridge, MA
Balkrishan (Simba) A Gill, Ph.D.DirectorCambridge, MA
Balkrishan (Simba) A Gill, Ph.D.Executive OfficerCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2018-03-23D/A$81.5M$81.5M
2018-02-20D$47.5M$47.5M
2018-02-12D/A$50.0M$50.0M

More